Professional Documents
Culture Documents
עילפון ואזו וגאלי
עילפון ואזו וגאלי
:
" ( )
. " ,
. " :
, . "
.
" ."
" ( ) :Tilt Test ,
, .
, ,
.
, " , .
," ( )
. " 74-67 ,
" . "
: ,
; , ( ,)fludrocortisone
( ;)Midodrine .
, " ,
.
, ,
:KEY WORDS
3
2
1 ,
,"
2 ,
,"
3 , ,"
,
, [ .]2 ,1 "
( ) 1907
"" ,
[ .]3 1932
, [ .]4"
( )Neurally Mediated Syncope
. , (
)1 66
[.]5
27
" ,
[ .]1
"
.
, , , ,
[ .]7-5
,
".
"
. , 47 31 ,
.]2[ 15
[ .]2 Ganzeboom'
(
39 ,)21 "
[ .]8 ,
[ .]9 ,8
,
[ .]2 "
:
.
"
,
[.]8 ,7
27
:1
( ) []21
( )
()Carotid Sinus
( , , )
Neuralgia Glossopharyngeal Trigeminal
( )Post-Prandial ,
(
, )
( , ,,
" )
(Familial
)Disautonomia, Multiple System Atrophy
( .
)
Sinus Node
Supraventricular and Ventricular Tachycardias
(Long QT Syndrome, Brugada Syndrome, Short
)QT,,arrhythmogenic Right Ventricular Dysplasia
()Myxoma
()
( )
"" ()Vascular Steal Syndromes
28
" .
( )
[ ,]10 , [.]11
,
(
, ) .
, ,
" ' ()Benzold-Jarisch Reflex
[ .]10
, ,
, ",
,Tilt-Test ,
( )Epinephrine ( )Renin ,
()
[ .]12
[ ,]13
( ,]14[ )Myocardial Contractility
( ,)Norepinephrine ( )Endothelin [.]12
[]15
(.]16[ )Vasopressin
7' 1 2010
,
, , , ,
, , , .
"
(Angiotensin-
,)Converting Enzyme [ACE] Inhibitors ,
7' 1 2010
:2
(")
"
"
80"
.
10" ( )
, "
Pulse Pressure
80-70"
.
, ,
Pulse Pressure
[.]19
() , , , .
[ .]18 ,
, " . '
"
[ .]20 "
, []21
[ .]22
, , ( )
[ .]2
, ,
.
.
/ "
, (
) .
( ),
"
,
[.]23 ,7
,
( ,
,
) . ,
,
(")
" , 85-50 [.]18
" ,
,
[.]1
, 95% ,48%
97 [ .]24
, ,
,
.
, ,
, , , , ,
( ).
, .
-
, ()EEG
, [.]1
' [ ]25
100 .
89% 91%
( .)3
. -
,
, ,
,
-
" ( )
.
.
( )Tilt Test
,
" , " [ .]24
," [ ,]26 ,5 ,2
29
7' 1 2010
:3
" ."
2 (.)<= 2
' []25
1 .1 : ,
, , ,
?Bifascicular Block
-5
2.2
?
-4
3.3 35
?
-3
4.4 ?
-2
5.5
?
6.6 ?
7 .7
?
30
.
."
,
[ .]2 70-60
" ,
[ .]26 74%-67%
[ .]27 30-20
400 g )Glyceryl Trinitrate( GTN
[ .]2
45-30 ,
[.]18
" " ( Isosorbid
,)Dinitrate ( ,)Isoproterenol
( ,)Clomipramine ( )Edrophonium [ .]18
( )Positivity Rate 85%
( 23
) [ .]28
,
.
," .
,
( .)Sick Sinus Syndrome
,
, .
. ,
[ .]2"
[.]2
"
. ,
[ .]2" [.]7
,
,
()Triggers
[ .]2
"
, , ,
( ,)Squatting (
.]18[ )1
[ .]21
" [.]29
[ .]30
,
[.]31
( )Tilt Training
( ,)Orthostatic Training
, " (
.]32[ )1
.
"
" ,
( )Standing Training
12-10 .
,
40-30 [.]21
[ .]34 ,33
46 " ,' '
.
[.]34
.
,ACE ,
. "
[.]35
,
[]37 ,36
7' 1 2010
. ,
, )Prevention of Syncope Trial( POST 208
( )Metoprolol
( ,)42
( .]37[ )42
( )Fludrocortisone
,
. ,
.
,
[ .]38
, ( 33 ) ,
, ,
, , [.]39
( ,)Midodrine ,
[.]40
( )Pro - Drug
( )Desglymidodrine
, ,
[ .]21
,
" , " ( )Piloerection
[.]41
" (
) (Serotonin
,Etilefrine ,Disopyramide ,)Selective Reuptake Inhibitors
Theophylline .]18[ Scopolamine
,
,Paroxetine .]18[ SSRIs
( ,)Carotid Sinus Syndrome
. "
.
( )
[ ,]21
, [.]2
. ,
,DDDR ( )Contractility ,
,DDI
[ .]42
[ .]43
()Asystolic Pauses
[.]21
3,877
, 9.8( 380)
[ .]44
:1
'
'
' , ( )Squatting .
' : .
( 15" ) .
.
. , .
, , -
30-20 . 20
.
.]21[ Elsevier
;Benditt DG., Nguyen JT., Syncope: therapeutic approaches. J Am Coll Cardiol, 2009; 12
53 (19): 1741-1751.
37
12 .
, 12
.
.
( 0.8 )
(
) [ .]2
[.]2
" ,
, , (
) [ .]44 ,2
( )
( ,
, ) .
31
2010 1 ' 7
) ,(
" .
.
" :
82099 , ,8
08-6812202 :
Arthur.shiyovich@gmail.com :"
,
.]7[
,
, .
.
,
7. , ,
.
.2004 ,01.01
. ,
8. Ganzeboom KS., Colman
N., Reitsma JB. & al,
Prevalence and triggers
of syncope in medical
students. Am J Cardiol,
2003; 91: 1006-1008.
9. Alboni P., Brignole M.,
Degli Uberti EC., Is
vasovagal syncope a
disease? Europace,
2007; 9 (2): 83-87.
10. Abi-Samra F., Maloney JD.,
Fouad-Tarazi FM. & al, The
usefulness of head-up tilt
testing and hemodynamic
investigations in the
workup of syncope of
unknown origin. Pacing
Clin Electrophysiol, 1988;
11: 1202-1214.
11. Hainsworth R., Syncope:
what is the trigger? Heart,
2003; 89: 123-124.
12. Ellenbogen KA., Morillo
CA., Wood MA. & al,
Neural monitoring of
vasovagal syncope. Pacing
Clin Electrophysiol,
1997; 20: 788-794.
13. Morillo CA., Eckberg DL.,
Ellenbogen KA. & al,
Vagal and sympathetic
mechanisms in patients
with orthostatic vasovagal
syncope. Circulation,
1997; 96: 2509-2513.
14. Mizumaki K., Fujiki A., Tani
M. & al, Left ventricular
dimensions and autonomic
balance during head-up
tilt differ between patients
with isoproterenoldependent and
isoproterenol-independent
Cardiol, 2009; 53
(19): 1741-1751.
22. Giada F., Silvestri I., Rossillo
A. & al, Psychiatric profile,
quality of life and risk of
syncopal recurrence in
patients with tilt-induced
vasovagal syncope.
Europace, 2005; 7: 465-471.
23. , ,
,
:
.
.58-53 :)2( 1 ;2004 ,
24. Alboni P., Brignole M.,
Menozzi C. & al, Diagnostic
value of history in patients
with syncope with or
without heart disease.
J Am Coll Cardiol, 2001;
37: 1921-1928.
25. Sheldon R., Rose S., Connolly
S.& al, Diagnostic Criteria
for Vasovagal Syncope
Based on a Quantitative
History. Eur Heart J,
2006; 27: 344-350.
26. Kenny RA., OShea D.,
Parry SW., The Newcastle
protocols for head-up
tilt table testing in the
diagnosis of vasovagal
syncope, carotid sinus
hypersensitivity, and
related disorders. Heart,
2000; 83: 564-569.
27. Fitzpatrick A., Sutton R.,
Tilting towards a diagnosis
in recurrent unexplained
syncope. Lancet, 1989;
1: 658-660.
28. Hainsworth R., el-Bedawi
KM., Orthostatic tolerance
in patients with unexplained
syncope. Clin Auton Res,
1994; 4: 239-244.
32
33
2010 1 ' 7
syncope. Am J Cardiol,
2001; 88: 80-83.
41. Parry SW., Kenny RA.,
The management of
vasovagal syncope. Q J
Med, 1999; 92: 697-705.
42. Deharo JC., Brunetto
AB., Bellocci F. & al,
DDDR pacing driven
by contractility versus
DDI pacing in vasovagal
syncope: a multicenter,
randomized study. Pacing
Clin Electrophysiol,
2003; 26: 447-450.
43. Brignole M., International
Study on Syncope of
Uncertain Aetiology 3
(ISSUE 3): pacemaker
therapy for patients with
asystolic neurallymediated
syncope: rationale and
study design. Europace,
2007; 9: 25-30.
44. Sorajja D., Nesbitt GC.,
Hodge DO. & al, Syncope
while driving: clinical
characteristics, causes, and
prognosis. Circulation,
2009; 120 (11): 928-934.